Fecal Calprotectin Test for Crohn's Disease: Full Guide

If you have ever stared at a lab report showing a calprotectin number and wondered whether it is good, bad, or meaningless, you are not alone. The fecal calprotectin test for Crohn's disease has become one of the most useful non-invasive tools for monitoring intestinal inflammation, and recent guidelines from the ACG (2025) and AGA (2023) have cemented its role in routine care. Below, we break down what the test measures, what your numbers actually mean, and how to use this simple stool test to stay ahead of flares - often without needing a scope.

Key Takeaways

• Fecal calprotectin is a stool-based marker of intestinal inflammation with roughly 81% sensitivity and 87% specificity for detecting IBD at the 50 micrograms per gram cutoff (4)
• The 2025 ACG guideline recommends a calprotectin cutoff of greater than 50 to 100 mg/g to distinguish inflammatory from non-inflammatory bowel disease (1)
• A calprotectin level below 150 micrograms per gram combined with normal CRP can rule out active inflammation during remission, potentially avoiding endoscopy (2)(3)
• NSAIDs, proton pump inhibitors, recent infections, and menstrual blood can elevate calprotectin and produce false positives - always share this context with your GI team
• Trends over time are more reliable than any single calprotectin number, so use the same lab and track results consistently

What Is Fecal Calprotectin and Why It Matters in Crohn's Disease

Fecal calprotectin is a protein released by white blood cells called neutrophils when the intestinal lining is inflamed. Unlike general inflammation markers such as CRP, calprotectin is specific to the gut, making it a direct window into what is happening in your bowel rather than a reflection of inflammation elsewhere in the body (6).

How calprotectin signals gut inflammation

When Crohn's disease flares, neutrophils flood the intestinal wall and release calprotectin into the bowel lumen. The protein is remarkably stable in stool - intact for up to seven days at room temperature - which is why a simple at-home sample can reflect inflammation that might otherwise require endoscopy to detect (6). The 2025 ACG guideline and the AGA 2023 biomarkers guideline both now recommend calprotectin for diagnosis, monitoring remission, and detecting postoperative recurrence (1)(2)(3).

Calprotectin vs. CRP and other IBD biomarkers

CRP measures systemic inflammation and can rise with a cold, a joint flare, or stress. Calprotectin is gut-specific, which makes it far more useful for answering the question that matters most: is my bowel inflamed right now? That said, calprotectin and CRP complement each other. The AGA guideline uses both together - for example, calprotectin below 150 micrograms per gram plus normal CRP is enough to rule out active Crohn's inflammation without a scope (2)(3). For a broader look at non-invasive monitoring approaches, our guide on intestinal ultrasound for Crohn's disease covers another technology that pairs well with calprotectin testing.

How the Test Works and What to Expect at Home

The test itself is straightforward - easier than many patients expect - but a few practical details can make the difference between an accurate result and a misleading one.

Step-by-step: collecting your stool sample

Your lab will provide a collection kit with a container and scoop. Pass a bowel movement into a clean, dry container (not directly into the toilet), transfer a small amount into the collection tube, and avoid contaminating with urine, toilet water, or toilet paper. Seal and deliver to the lab - most assays accept samples within about three days and many do not require refrigeration.

Medications and habits that can skew results

This is where context matters. Several common factors can raise calprotectin independently of Crohn's disease activity, leading to false positives (4)(6):

• NSAIDs such as ibuprofen and naproxen are known to cause intestinal mucosal damage and elevate calprotectin
• Proton pump inhibitors (omeprazole, pantoprazole) can modestly raise levels
• Recent gastrointestinal infections may take weeks to resolve and keep calprotectin elevated
• Menstrual blood, hemorrhoidal bleeding, and recent colonoscopy prep can all contaminate results

Always tell your gastroenterologist about any of these before testing. Timing the test to avoid these confounders helps ensure the number reflects your actual Crohn's activity.

Understanding Your Numbers: 2025 ACG and AGA Cutoff Values

The numbers on your lab report are only useful if you know which cutoffs apply. Diagnostic, monitoring, and postoperative scenarios each use different thresholds - and these have been sharpened by the latest guidelines.

Diagnostic cutoffs: ruling IBD in or out

The 2025 ACG guideline recommends a fecal calprotectin cutoff of greater than 50 to 100 mg/g to distinguish inflammatory from non-inflammatory disease in patients with new GI symptoms (1). At the 50 micrograms per gram threshold, pooled data show 81% sensitivity and 87% specificity for detecting IBD (4). A normal calprotectin makes active IBD unlikely, while an elevated one warrants further investigation - especially helpful if your doctor is unsure whether your symptoms point to Crohn's or something like IBS.

Monitoring cutoffs: remission vs. active disease

For patients already diagnosed and living with Crohn's, the AGA 2023 biomarkers guideline provides clear guidance: in symptomatic remission, a fecal calprotectin level below 150 micrograms per gram combined with normal CRP rules out active inflammation, potentially avoiding the need for endoscopy (2)(3). This is one of the most patient-friendly advances in recent years - it means fewer scopes for people who are feeling well.

In patients with moderate to severe symptoms, elevated fecal calprotectin or CRP supports active inflammation and may guide treatment changes without immediate endoscopy (2)(3). Understanding the interplay between calprotectin numbers and your daily symptoms is key to recognizing flares early.

Postoperative cutoffs: detecting recurrence after surgery

After ileocolonic resection, catching disease recurrence before symptoms return can change outcomes. A meta-analysis of 588 postoperative Crohn's disease patients found that a calprotectin threshold of 150 micrograms per gram detected endoscopic recurrence with 70% sensitivity and 69% specificity, and serial testing could defer colonoscopy in up to 70% of patients (5). For patients recovering from surgery, regular calprotectin checks offer a way to monitor healing without repeated scopes.

How Often Should You Test?

There is no universal schedule, and testing without a clinical reason is not supported by the evidence. The AGA guideline emphasizes pairing biomarker checks with symptoms or treatment changes rather than testing on autopilot (2)(3).

Testing during a flare or symptom change

When new symptoms appear - increased diarrhea, blood, cramping, fatigue - calprotectin helps answer whether bowel inflammation is the cause. A high result supports advancing to imaging or endoscopy, while a normal result may reassure you that something other than active Crohn's is driving symptoms.

Testing while in remission

Many gastroenterologists check calprotectin every 3 to 6 months in stable remission to catch subclinical inflammation before it leads to a flare. As researchers develop emerging non-invasive monitoring tools like sweat-based biomarkers, calprotectin remains the current standard for surveillance between scopes.

Testing after starting or switching biologic therapy

After starting a biologic such as an anti-TNF, vedolizumab, or ustekinumab, repeat calprotectin testing is commonly used at induction and again 3 to 6 months later. A falling calprotectin is one of the clearest early signals that therapy is working at the intestinal level.

Strengths and Limitations of Fecal Calprotectin

No test is perfect, and calprotectin is most useful when you understand both what it does well and where it falls short.

What the test does well

Calprotectin is non-invasive, inexpensive compared to imaging, and correlates well with endoscopic findings. Across studies, sensitivity for IBD ranges from 80% to 98%, with specificity from 68% to 96% depending on cutoff and population (4).

Where it falls short

Isolated small bowel Crohn's disease can produce lower calprotectin values than colonic disease, occasionally falling below the diagnostic cutoff despite active inflammation (4). Single values can also fluctuate between bowel movements, which is why trends over time are more informative than any one number.

Conditions other than Crohn's that raise calprotectin

Calprotectin is not specific to Crohn's disease. It can also be elevated by infectious gastroenteritis, NSAID-induced enteropathy, celiac disease, colorectal polyps or cancer, and acute diverticulitis (4)(6). An elevated result always needs clinical interpretation - it is a signal, not a diagnosis.

Practical Tips for Patients Using Calprotectin Testing

Getting the most out of this test takes a bit of organization, but the payoff is better conversations with your GI team and fewer unnecessary procedures.

Working with your GI team

Ask your gastroenterologist which lab and assay are being used. Cutoff values vary between manufacturers, so trends are most reliable when every test comes from the same lab. If you switch labs, mention this so your doctor does not overreact to a number that reflects a different assay range.

If your insurer denies the test, ask your GI team about prior authorization templates that cite the AGA biomarkers guideline, which includes 11 conditional recommendations covering biomarker use across multiple disease states (2)(3). Coverage varies by country and plan, but a well-documented request often succeeds.

Tracking your results over time

Keep a simple log of your calprotectin results alongside symptoms, medications, and any recent infections or NSAID use. The goal is spotting patterns - a slowly climbing calprotectin over three consecutive tests tells a very different story than a single elevated reading after a stomach bug. Use calprotectin alongside - not instead of - clinical assessment and periodic endoscopy or imaging, especially before major treatment decisions.

Frequently Asked Questions

What does a fecal calprotectin level of 200 mean?

A calprotectin of 200 micrograms per gram is above the monitoring cutoff of 150 and suggests active intestinal inflammation (2)(3). However, recent NSAID use, an infection, or lab variability could contribute. Your gastroenterologist will interpret this alongside symptoms, CRP, and clinical history.

Can fecal calprotectin replace colonoscopy for Crohn's monitoring?

Not entirely, but it can reduce how often you need one. The AGA guideline supports using calprotectin below 150 micrograms per gram plus normal CRP to rule out active inflammation during remission, often avoiding endoscopy (2)(3). For major decisions like changing therapy or evaluating post-surgical recurrence, endoscopy or imaging typically remains necessary.

Is the fecal calprotectin test accurate for small bowel Crohn's disease?

Calprotectin is most reliable for colonic and ileocolonic disease. Isolated small bowel Crohn's can produce lower values that fall below the cutoff despite active inflammation (4). If your disease is primarily in the small intestine, your doctor may rely more on imaging alongside calprotectin.

How long does it take to get fecal calprotectin results?

Most labs return results within 3 to 7 business days. Some specialized IBD clinics offer faster turnaround. Point-of-care calprotectin tests exist but are not yet widely available.

Can I do anything to prepare for the test?

Avoid NSAIDs for at least two weeks before testing if possible. Mention any proton pump inhibitors, recent infections, or hemorrhoidal bleeding to your doctor. No dietary preparation is needed.

Is fecal calprotectin covered by insurance?

Coverage varies significantly by country and insurer. In many European healthcare systems, the test is routinely covered. In the United States, most insurance plans cover it when medically justified, but prior authorization may be required. If denied, ask your GI team to submit an appeal citing the AGA 2023 biomarkers guideline (2)(3), which provides strong evidence-based support for routine use.

What should I ask my doctor about my calprotectin results?

Consider asking: "Which assay did the lab use, and what cutoff applies?" - "How does this number compare to my previous results?" - "Given my current medications and symptoms, is this result reliable?" - "Do we need to follow up with imaging or a scope, or can we monitor?" These questions help ensure you and your doctor are interpreting the number in full context.

References

1. Zhai, Z., Dalal, R., et al. Updated 2025 ACG Clinical Guideline for the Management of Crohn's Disease. American College of Gastroenterology, 2025. Read guideline
2. Ananthakrishnan, A., et al. AGA Clinical Practice Guideline on the Role of Biomarkers for the Management of Crohn's Disease. Gastroenterology, 2023. Read study
3. American Gastroenterological Association. The Role of Biomarkers for the Management of Crohn's Disease - AGA Clinical Guidance. 2023. Read guidance
4. Kapel, N., et al. Fecal Calprotectin for the Diagnosis and Management of Inflammatory Bowel Diseases. Clinical and Translational Gastroenterology, 2023. Read study
5. Tham, Y., et al. Fecal calprotectin for detection of postoperative endoscopic recurrence in Crohn's disease: systematic review and meta-analysis. Therapeutic Advances in Gastroenterology, 2018. Read study
6. MedlinePlus. Calprotectin Stool Test. National Library of Medicine, 2024. Read article